Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pu Reun, Roh"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The introduction of immune checkpoint inhibitors (ICIs) represents a key shift in the management strategy for patients with hepatocellular carcinoma (HCC). However, there is a paucity of predictive biomarkers that facilitate the identification of pat
Externí odkaz:
https://doaj.org/article/71f2b2bf25fd4d9eab1d4499825ef661
Autor:
Sung-Min Kim, Won-Hee Hur, Byung-Yoon Kang, Sung-Won Lee, Pu-Reun Roh, Dong-Jun Park, Pil-Soo Sung, Seung-Kew Yoon
Publikováno v:
Cells, Vol 10, Iss 7, p 1742 (2021)
Transforming growth factor-β (TGF-β) has been identified as an inducer of hepatocyte epithelial–mesenchymal transition (EMT), which triggers liver fibrosis. Death-associated protein 6 (Daxx) is known to be associated with the TGF-β-induced apopt
Externí odkaz:
https://doaj.org/article/1520a5fd9e724b83b7221d7359bf01e7
Autor:
Pu Reun Roh, Sung Min Kim, Byung-Yoon Kang, Kyoung Do Mun, Jong Geun Park, Min Woo Kang, Wonhee Hur, Ji Won Han, Heechul Nam, Seung Kew Yoon, Pil Soo Sung
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 156
Although the prevalence of nonalcoholic steatohepatitis (NASH) is rapidly increasing, effective therapy is lacking. Tenofovir alafenamide (TAF) is a widely used antiviral drug for hepatitis B. In this study, we investigated the potential pharmacologi
Autor:
BYUNG-YOON KANG, SUNG MIN KIM, WONHEE HUR, PU REUN ROH, JI WON HAN, PIL SOO SUNG, EUNYOUNG TAK, WON JONG KIM, LONG JIN, HO JONG CHUN, SEUNG KEW YOON
Publikováno v:
Anticancer research. 42(7)
Locoregional treatments for hepatocellular carcinoma (HCC) induce immunogenic cell death and a tumor-specific immune response, but infiltration and activation of immune cells in the liver have not been clearly described. Transarterial chemoembolizati
Autor:
Pil Soo, Sung, Dong Jun, Park, Pu Reun, Roh, Kyoung Do, Mun, Sung Woo, Cho, Gil Won, Lee, Eun Sun, Jung, Sung Hak, Lee, Jeong Won, Jang, Si Hyun, Bae, Jong Young, Choi, Jonghwan, Choi, Jaegyoon, Ahn, Seung Kew, Yoon
Publikováno v:
Journal for immunotherapy of cancer. 10(5)
IgA neutralizes pathogens to prevent infection at mucosal sites. However, emerging evidence shows that IgA contributes to aggravating inflammation or dismantling antitumor immunity in human diseased liver. The aim of this study was to elucidate the r
Autor:
Wonhee Hur, Seung Kew Yoon, Won Jong Kim, Byung-Yoon Kang, Ji Won Han, Eunyoung Tak, Pil Soo Sung, Ho Jong Chun, Pu Reun Roh, Long Jin, Sungmin Kim
Background: Anticancer strategies using nanocarrier systems via the enhanced permeability and retention (EPR) effect and tumor targeting have been explored in various cancers. In previous studies, the anticancer effect of polymerized phenylboronic ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02c8fcbc2f7a40a1583c35ec6aea88ab
https://doi.org/10.21203/rs.3.rs-858146/v1
https://doi.org/10.21203/rs.3.rs-858146/v1
Autor:
Pil-Soo Sung, Sung Min Kim, Byung-Yoon Kang, Wonhee Hur, Dong-Jun Park, Seung Kew Yoon, Sung Won Lee, Pu-Reun Roh
Publikováno v:
Cells
Volume 10
Issue 7
Cells, Vol 10, Iss 1742, p 1742 (2021)
Volume 10
Issue 7
Cells, Vol 10, Iss 1742, p 1742 (2021)
Transforming growth factor-β (TGF-β) has been identified as an inducer of hepatocyte epithelial–mesenchymal transition (EMT), which triggers liver fibrosis. Death-associated protein 6 (Daxx) is known to be associated with the TGF-β-induced apopt
Autor:
Pil Soo Sung, Dong Jun Park, Pu Reun Roh, Kyoung Do Mun, Sung Woo Cho, Gil Won Lee, Eun Sun Jung, Sung Hak Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jonghwan Choi, Jaegyoon Ahn, Seung Kew Yoon
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e003618
BackgroundIgA neutralizes pathogens to prevent infection at mucosal sites. However, emerging evidence shows that IgA contributes to aggravating inflammation or dismantling antitumor immunity in human diseased liver. The aim of this study was to eluci